全文获取类型
收费全文 | 3956篇 |
免费 | 292篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 89篇 |
妇产科学 | 88篇 |
基础医学 | 592篇 |
口腔科学 | 58篇 |
临床医学 | 378篇 |
内科学 | 724篇 |
皮肤病学 | 157篇 |
神经病学 | 455篇 |
特种医学 | 99篇 |
外科学 | 357篇 |
综合类 | 32篇 |
一般理论 | 8篇 |
预防医学 | 363篇 |
眼科学 | 52篇 |
药学 | 317篇 |
中国医学 | 1篇 |
肿瘤学 | 434篇 |
出版年
2023年 | 35篇 |
2022年 | 57篇 |
2021年 | 110篇 |
2020年 | 71篇 |
2019年 | 93篇 |
2018年 | 106篇 |
2017年 | 75篇 |
2016年 | 98篇 |
2015年 | 73篇 |
2014年 | 106篇 |
2013年 | 162篇 |
2012年 | 206篇 |
2011年 | 202篇 |
2010年 | 137篇 |
2009年 | 147篇 |
2008年 | 202篇 |
2007年 | 188篇 |
2006年 | 215篇 |
2005年 | 203篇 |
2004年 | 168篇 |
2003年 | 179篇 |
2002年 | 146篇 |
2001年 | 86篇 |
2000年 | 106篇 |
1999年 | 87篇 |
1998年 | 41篇 |
1997年 | 48篇 |
1996年 | 31篇 |
1995年 | 36篇 |
1994年 | 34篇 |
1993年 | 26篇 |
1992年 | 51篇 |
1991年 | 54篇 |
1990年 | 56篇 |
1989年 | 41篇 |
1988年 | 56篇 |
1987年 | 50篇 |
1986年 | 55篇 |
1985年 | 62篇 |
1984年 | 30篇 |
1983年 | 28篇 |
1982年 | 28篇 |
1980年 | 19篇 |
1979年 | 28篇 |
1978年 | 24篇 |
1977年 | 21篇 |
1976年 | 18篇 |
1975年 | 20篇 |
1974年 | 20篇 |
1973年 | 18篇 |
排序方式: 共有4257条查询结果,搜索用时 15 毫秒
51.
Matteo Morotti Christos E. Zois Rokaya El-Ansari Madeleine L. Craze Emad A. Rakha Shih-Jung Fan Alessandro Valli Syed Haider Deborah C. I. Goberdhan Andrew R. Green Adrian L. Harris 《British journal of cancer》2021,124(2):494
Background Glutamine (Gln) is an abundant nutrient used by cancer cells. Breast cancers cells and particularly triple-receptor negative breast cancer (TNBC) are reported to be dependent on Gln to produce the energy required for survival and proliferation. Despite intense research on the role of the intracellular Gln pathway, few reports have focussed on Gln transporters in breast cancer and TNBC.Methods The role and localisation of the Gln transporter SLC38A2/SNAT2 in response to Gln deprivation or pharmacological stresses was examined in a panel of breast cancer cell lines. Subsequently, the effect of SLC38A2 knockdown in Gln-sensitive cell lines was analysed. The prognostic value of SLC38A2 in a cohort of breast cancer was determined by immunohistochemistry.Results SLC38A2 was identified as a strongly expressed amino acid transporter in six breast cancer cell lines. We confirmed an autophagic route of degradation for SLC38A2. SLC38A2 knockdown decreased Gln consumption, inhibited cell growth, induced autophagy and led to ROS production in a subgroup of Gln-sensitive cell lines. High expression of SLC38A2 protein was associated with poor breast cancer specific survival in a large cohort of patients (p = 0.004), particularly in TNBC (p = 0.02).Conclusions These results position SLC38A2 as a selective target for inhibiting growth of Gln-dependent breast cancer cell lines.Subject terms: Breast cancer, Cancer metabolism 相似文献
52.
Karine Marquis Fran?ois Maltais Yves Lacasse Yves Lacourcière Claudette Fortin Paul Poirier 《Canadian respiratory journal》2008,15(7):355-360
BACKGROUND AND OBJECTIVES:
The present pilot study was undertaken to evaluate the efficacy of an aerobic exercise training (AET) program alone or combined with an antihypertensive agent (irbesartan) to reduce blood pressure (BP) and enhance heart rate variability (HRV) in chronic obstructive pulmonary disease patients.METHODS:
Twenty-one patients were randomly assigned to a double-blind treatment with exercise and placebo (n=11) or exercise and irbesartan (n=10). Subjects underwent 24 h BP monitoring and 24 h electrocardiographic recording before and after the 12-week AET. HRV was investigated using three indexes from the power spectral analysis and three indexes calculated from the time domain. The AET program consisted of exercising on a calibrated ergocycle for 30 min three times per week. Five patients in the placebo group were excluded during follow-up because they were not compliant.RESULTS:
There was no change in 24 h systolic and diastolic BP before (130±14 mmHg and 70±3 mmHg, respectively) and after (128±8 mmHg and 70±8 mmHg, respectively) exercise training in the placebo group, whereas in the irbesartan group systolic and diastolic BP decreased from 135±9 mmHg and 76±9 mmHg to 126±12 mmHg and 72±8 mmHg, respectively (P<0.02). There were no changes in HRV parameters in either group.CONCLUSIONS:
The present study suggests that a 12-week AET program is not associated with a significant reduction in BP or enhancement in HRV, whereas an AET program combined with irbe-sartan is associated with a reduction in 24 h BP. 相似文献53.
Human bone marrow cells which had been incubated with [3H]uridine or [3H]leucine for I h were studied using the technique of electron microscope-autoradiography. The autoradiographs revealed the presence of newly-synthesized RNA and protein molecules within or on a proportion of (I) the primary and secondary granules in all classes of eosinophil precursors and (2) the secondary granules in eosinophil granulocytes. It is suggested that the granule-associated RNA molecules may be concerned with the synthesis of at least some of the new protein molecules which were incorporated into the limiting membrane or substance of eosinophil granules long after the immature primary granule stage. Studies of eosinophil precursors which had been incubated with [3H]thymidine for I h showed that the eosinophil granules do not label with this DNA precursor. 相似文献
54.
Hall JP Wiseman VL King MT Ross DL Kovoor P Zecchin RP Moir FM Robert Denniss A 《Heart, lung & circulation》2002,11(1):10-18
Background: Although there have been a number of economic evaluations of cardiac rehabilitation after acute myocardial infarction (AMI), none has considered only low-risk patients or control groups with no rehabilitation at all.Methods: An economic evaluation was included in a randomised controlled trial of patients following uncomplicated AMI. Eligible patients were randomised to return to normal activities after 6 weeks of standard rehabilitation (REHAB, n = 70) or to early return to normal activities 2 weeks after AMI with no formal rehabilitation (ERNA, n = 72). Outcomes were assessed weekly for 6 weeks, then 3, 6 and 12 months post-AMI. Outcomes included four quality of life (QOL) measures (physical abilities, distress, usual/social activities, self-care) and four measures of return to normal activities (paid and unpaid return to any work and to pre-AMI level of work). Statistical analysis included repeated-measures regression (QOL outcomes) and survival analysis (work outcomes).Results: There were no statistically significant differences between the two groups in any of the outcomes measured or in the use of other health services. The net cost that could be saved by the health service by targeting rehabilitation to high-risk patients was approximately $300 (Australian, 1999) per low-risk patient.Conclusions: Early return to normal activities without formal rehabilitation is cost-effective for low-risk patients. 相似文献
55.
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses 总被引:2,自引:0,他引:2
Hipp MM Hilf N Walter S Werth D Brauer KM Radsak MP Weinschenk T Singh-Jasuja H Brossart P 《Blood》2008,111(12):5610-5620
The tyrosine kinase inhibitors sorafenib and sunitinib are approved for the treatment of patients with malignant diseases. To analyze the possible use of these compounds in combination with immunotherapeutic approaches, we analyzed the effects of both inhibitors on the immunostimulatory capacity of human dendritic cells (DCs) and the induction of primary immune responses in vivo. Sorafenib, but not sunitinib, inhibits function of DCs, characterized by reduced secretion of cytokines and expression of CD1a, major histocompatibility complex, and costimulatory molecules in response to TLR ligands as well as by their impaired ability to migrate and stimulate T-cell responses. These inhibitory effects are mediated by inhibition of PI3 and MAP kinases and NFB signaling. In contrast, sorafenib had no influence on the phenotype and proliferation of T cells. To analyze the effects of both TKIs on cytotoxic T-cell induction in vivo, C57BL/6 mice were pretreated with sorafenib or sunitinib and immunized with OVA257-264 peptide. Sorafenib, but not sunitinib, application significantly reduced the induction of antigen-specific T cells. Numbers of regulatory T cells were reduced in peripheral blood mononuclear cells from mice treated with sunitinib. These results indicate that sunitinib, but not sorafenib, is suitable for combination with immunotherapeutic approaches for treatment of cancer patients. 相似文献
56.
A systematic review of acute kidney injury in pediatric allogeneic hematopoietic stem cell recipients 下载免费PDF全文
The process of allogeneic HSCT in children is associated with frequent AKI and mortality, but the epidemiology is not widely reported. The aim of this review was to summarize the available evidence on incidence, risk factors, timing, and prognosis of AKI in children following HSCT. We systematically reviewed all observational studies reporting incidence and outcomes of AKI in pediatric allogenic HSCT recipients. The minimum criteria for AKI were defined as an increase in sCr ≥ x1.5 or urine output ≤0.5 mL/kg/min over six h. Medline and Embase were searched until March 2014. From 993 electronic records, five were eligible for inclusion (n = 571 patients). The average incidence of AKI within the first 100 days following HSCT was 21.7% (range 11–42%), and the average time of onset was 4–6 wk post‐transplant. Risk factors for AKI included cyclosporine toxicity, amphotericin B and foscarnet, SOS, and having a mismatched donor. There were conflicting reports on whether AKI was associated with the development of CKD. AKI is a common and potentially life‐threatening complication following HSCT in children. Further quality observational studies are needed to accurately determine the epidemiology and prognosis of AKI in this population. 相似文献
57.
58.
Routine screening and related interventions significantly improve the effectiveness of emergency department detection and management of alcohol withdrawal syndrome 下载免费PDF全文
59.
Julia G. Poirier Laura L. Faye Apostolos Dimitromanolakis Andrew D. Paterson Lei Sun Shelley B. Bull 《Genetic epidemiology》2015,39(7):518-528
The “winner's curse” is a subtle and difficult problem in interpretation of genetic association, in which association estimates from large‐scale gene detection studies are larger in magnitude than those from subsequent replication studies. This is practically important because use of a biased estimate from the original study will yield an underestimate of sample size requirements for replication, leaving the investigators with an underpowered study. Motivated by investigation of the genetics of type 1 diabetes complications in a longitudinal cohort of participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Genetics Study, we apply a bootstrap resampling method in analysis of time to nephropathy under a Cox proportional hazards model, examining 1,213 single‐nucleotide polymorphisms (SNPs) in 201 candidate genes custom genotyped in 1,361 white probands. Among 15 top‐ranked SNPs, bias reduction in log hazard ratio estimates ranges from 43.1% to 80.5%. In simulation studies based on the observed DCCT/EDIC genotype data, genome‐wide bootstrap estimates for false‐positive SNPs and for true‐positive SNPs with low‐to‐moderate power are closer to the true values than uncorrected naïve estimates, but tend to overcorrect SNPs with high power. This bias‐reduction technique is generally applicable for complex trait studies including quantitative, binary, and time‐to‐event traits. 相似文献
60.